Berlin - Delayed Quote EUR
Green Thumb Industries Inc (R9U2.BE)
4.6240
-0.0420
(-0.90%)
As of 11:45:08 AM GMT+2. Market Open.
Loading Chart for R9U2.BE
- Previous Close
4.6660 - Open
4.6300 - Bid 4.4160 x --
- Ask 4.9020 x --
- Day's Range
4.6240 - 4.6300 - 52 Week Range
4.3620 - 11.8800 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: R9U2.BE
View MorePerformance Overview: R9U2.BE
Trailing total returns as of 6/4/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
R9U2.BE
36.87%
S&P/TSX Composite index (^GSPTSE)
7.34%
1-Year Return
R9U2.BE
57.85%
S&P/TSX Composite index (^GSPTSE)
20.24%
3-Year Return
R9U2.BE
55.26%
S&P/TSX Composite index (^GSPTSE)
27.11%
5-Year Return
R9U2.BE
49.74%
S&P/TSX Composite index (^GSPTSE)
70.19%
Compare To: R9U2.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
4.6240
-0.90%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.1400
+0.88%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.1700
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1700
-6.08%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.6580
+1.28%
Mkt Cap EUR 661.282M
Industry Drug Manufacturers—Specialty & Generic
3.4380
-1.77%
Mkt Cap EUR 651.446M
Industry Drug Manufacturers—Specialty & Generic
0.3551
-0.81%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.3511
+0.37%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.3494
-1.55%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4990
-0.04%
Mkt Cap EUR 173.094M
Industry Drug Manufacturers—Specialty & Generic
Statistics: R9U2.BE
View MoreValuation Measures
As of 6/3/2025
Market Cap
1.09B
Enterprise Value
1.36B
Trailing P/E
25.44
Forward P/E
23.87
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.13
Price/Book (mrq)
0.70
Enterprise Value/Revenue
1.37
Enterprise Value/EBITDA
4.24
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--